XML 76 R64.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCK-BASED COMPENSATION. (Restricted Shares and Stock Units) (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted-average fair value of nonvested restricted shares and restricted stock units at December 31, 2017 (in dollars per share) $ 82.37    
Weighted-average fair value of restricted shares and restricted stock units vested (in dollars per share) 79.32    
Weighted-average fair value of restricted shares and restricted stock units forfeited (in dollars per share) 79.74    
Weighted-average fair value of nonvested restricted shares and restricted stock units at December 31, 2018 (in dollars per share) $ 87.07 $ 82.37  
Value at vest date $ 160.9    
Vested stock units (in shares) 47,639    
Time-based [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted-average fair value of restricted shares and restricted stock units granted (in dollars per share) $ 92.37    
Performance-based [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted-average fair value of restricted shares and restricted stock units granted (in dollars per share) $ 92.03    
Restricted shares and restricted stock units [Member] | Compensation and related costs [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Stock-based compensation expense $ 181.8 $ 124.0 $ 116.7
Restricted shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested at December 31, 2017 (in shares) 473,115    
Vested (in shares) (330,920)    
Forfeited (in shares) (14,006)    
Nonvested at December 31, 2018 (in shares) 136,964 473,115  
Restricted shares [Member] | Time-based [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Grants (in shares) 8,775    
Restricted shares [Member] | Performance-based [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Grants (in shares) 0    
Nonvested at December 31, 2018 (in shares) 2,400    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Nonvested shares where performance threshold has been met (in shares) 2,400    
Restricted stock units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested at December 31, 2017 (in shares) 5,556,911    
Vested (in shares) (1,412,089)    
Forfeited (in shares) (139,921)    
Nonvested at December 31, 2018 (in shares) 6,603,920 5,556,911  
Restricted stock units [Member] | Time-based [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Grants (in shares) 2,438,198    
Restricted stock units [Member] | Performance-based [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Grants (in shares) 160,821    
Nonvested at December 31, 2018 (in shares) 473,615    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Nonvested shares where performance threshold has been met (in shares) 198,340